Sphingolipids
Invitrogen™ NBD C6-Ceramide (6-((N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)amino)hexanoyl)Sphingosine)
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ NBD C6-Ceramide Complexed to BSA
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ BODIPY™ FL C5-Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ BODIPY™ TR Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ BODIPY™ FL C5-Lactosylceramide complexed to BSA
The green-fluorescent BODIPY™ FL C5 lactosylceramide complexed to BSA can be used in sphingolipid transport and metabolism mechanisms.
Invitrogen™ BODIPY™ FL C5-Ceramide (N-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Pentanoyl)Sphingosine)
Useful in cellular imaging and cell tracing and tracking
Enzo Life Sciences Dihydrosphingosine, D-erythro (50 mg). CAS: 764-22-7
Biosynthetic precursor of sphingosine. Inhibitor of protein kinase C (PKC). Blocks phospholipases A2 (PLA2) and the D-sphingosine precursor. Alternative name: D-erythro-Sphingosine, Dihydro-, Sphinganine. Purity: ≥98% (TLC). Solubility: Soluble in 100% ethanol (25mg/ml, warm) or DMSO (25mg/ml, warm). Long Term Storage: -20°C.
Cayman Chemical C6 NBD dihydro Ceramide d18
Structurally identical to C6 NBD ceramide, but contains a saturated bond in the C-4/C-5 position of the sphingosine backbone
Avanti Polar Lipids C18:0-d7 GD3 Ceramide (d18:1/18:0-d7), synthetic, 100ug
GD3 ceramide is the main ganglioside within human breast milk. GD3 Ceramides are critical for apoptosis and present in high quantities in various tumor species. This GD2 Ceramide is the deuterated version, which will enable the easier study of structure, dynamics, and function of cell membranes.
